Authors:
MULHOLLAND GK
WIELAND DM
KILBOURN MR
FREY KA
SHERMAN PS
CAREY JE
KUHL DE
Citation: Gk. Mulholland et al., [F-18] FLUOROETHOXY-BENZOVESAMICOL, A PET RADIOTRACER FOR THE VESICULAR ACETYLCHOLINE TRANSPORTER AND CHOLINERGIC SYNAPSES, Synapse, 30(3), 1998, pp. 263-274
Authors:
WROBEL MC
CAREY JE
SHERMAN PS
KILBOURN MR
Citation: Mc. Wrobel et al., SIMPLIFYING THE DOSIMETRY OF CARBON-11-LABELED RADIOPHARMACEUTICALS, The Journal of nuclear medicine, 38(4), 1997, pp. 654-660
Citation: Cs. Ryan et al., PATTERNS OF SERVICES AND CONSUMER OUTCOME IN AN INTENSIVE CASE-MANAGEMENT PROGRAM, Journal of consulting and clinical psychology, 65(3), 1997, pp. 485-493
Authors:
KILBOURN MR
FREY KA
VANDERBORGHT T
SHERMAN PS
Citation: Mr. Kilbourn et al., EFFECTS OF DOPAMINERGIC DRUG TREATMENTS ON IN-VIVO RADIOLIGAND BINDING TO BRAIN VESICULAR MONOAMINE TRANSPORTERS, Nuclear medicine and biology, 23(4), 1996, pp. 467-471
Authors:
GILDERSLEEVE DL
VANDORT ME
JOHNSON JW
SHERMAN PS
WIELAND DM
Citation: Dl. Gildersleeve et al., SYNTHESIS AND EVALUATION OF [I-123] IODO-PK11195 FOR MAPPING PERIPHERAL-TYPE BENZODIAZEPINE RECEPTORS (OMEGA(3)) IN HEART, Nuclear medicine and biology, 23(1), 1996, pp. 23-28
Authors:
SMUKLER M
SHERMAN PS
SREBNIK DS
UEHARA ES
Citation: M. Smukler et al., DEVELOPING LOCAL-SERVICE STANDARDS FOR MANAGED MENTAL-HEALTH-SERVICES, Administration and policy in mental health, 24(2), 1996, pp. 101-116
Citation: Mr. Kilbourn et al., IN-VIVO STUDIES OF ACETYLCHOLINESTERASE ACTIVITY USING A LABELED SUBSTRATE, N-[C-11]METHYLPIPERDIN-4-YL PROPIONATE ([C-11]PMP), Synapse, 22(2), 1996, pp. 123-131
Authors:
VANDORT ME
KIM JH
SHERMAN PS
TLUCZEK L
WIELAND DM
Citation: Me. Vandort et al., C-11 LABELED 2-HYDROXYDESIPRAMINE - A POTENTIAL RADIOTRACER FOR THE CARDIAC NOREPINEPHRINE TRANSPORTER, The Journal of nuclear medicine, 37(5), 1996, pp. 192-192
Authors:
JUNG YW
FREY KA
MULHOLLAND GK
DELROSARIO R
SHERMAN PS
RAFFEL DM
VANDORT ME
KUHL DE
GILDERSLEEVE DL
WIELAND DM
Citation: Yw. Jung et al., VESAMICOL RECEPTOR MAPPING OF BRAIN CHOLINERGIC NEURONS WITH RADIOIODINE-LABELED POSITIONAL ISOMERS OF BENZOVESAMICOL, Journal of medicinal chemistry, 39(17), 1996, pp. 3331-3342
Authors:
LEE LC
VANDERBORGHT TV
SHERMAN PS
FREY KA
KILBOURN MR
Citation: Lc. Lee et al., IN-VITRO AND IN-VIVO STUDIES OF BENZISOQUINOLINE LIGANDS FOR THE BRAIN SYNAPTIC VESICLE MONOAMINE TRANSPORTER, Journal of medicinal chemistry, 39(1), 1996, pp. 191-196
Citation: Mr. Kilbourn et al., MUTANT MOUSE STRAINS AS MODELS FOR IN-VIVO RADIOTRACER EVALUATIONS - [C-11]METHOXYTETRABENAZINE ([C-11]MTBZ) IN TOTTERING MICE, Nuclear medicine and biology, 22(5), 1995, pp. 565-567
Authors:
VANDORT ME
JUNG YW
SHERMAN PS
KILBOURN MR
WIELAND DM
Citation: Me. Vandort et al., FLUORINE FOR HYDROXY SUBSTITUTION IN BIOGENIC-AMINES - ASYMMETRIC-SYNTHESIS AND BIOLOGICAL EVALUATION OF FLUORINE-18-LABELED BETA-FLUOROPHENYLALKYLAMINES AS MODEL SYSTEMS, Journal of medicinal chemistry, 38(5), 1995, pp. 810-815
Authors:
SNYDER SE
KUME A
JUNG YW
CONNER SE
SHERMAN PS
ALBIN RL
WIELAND DM
KILBOURN MR
Citation: Se. Snyder et al., SYNTHESIS OF CARBON-11-LABELED, FLUORINE-18-LABELED, AND IODINE-125-LABELED GABA(A)-GATED CHLORIDE-ION CHANNEL BLOCKERS - SUBSTITUTED 5-TERT-BUTYL-2-PHENY1-1,3-DITHIANES AND 5-TERT-BUTYL-2-PHENY1-1,3-DITHIANE-OXIDES, Journal of medicinal chemistry, 38(14), 1995, pp. 2663-2671
Citation: Jn. Dasilva et al., CHARACTERIZATION OF [C-11] TETRABENAZINE AS AN IN-VIVO RADIOLIGAND FOR THE VESICULAR MONOAMINE TRANSPORTER, Nuclear medicine and biology, 21(2), 1994, pp. 151-156
Citation: Rb. Delrosario et al., [C-11] PHENYLEPHRINE MARKER FOR NEURONAL HEART MAO, The Journal of nuclear medicine, 35(5), 1994, pp. 160000007-160000007
Authors:
SNYDER SE
CONNOR S
SHERMAN PS
KILBOURN MR
Citation: Se. Snyder et al., C-11 AND F-18 LABELING OF GABA(A)-GATED CHLORIDE-ION CHANNEL BLOCKERS- SUBSTITUTED 5-T-BUTYL-2-PHENYL-1,3-DITHIANES, The Journal of nuclear medicine, 35(5), 1994, pp. 160000072-160000072
Citation: Me. Vandort et al., SEARCH FOR KINETIC RICHNESS - EVALUATION OF STEREOISOMERS OF [C-11] HED, The Journal of nuclear medicine, 35(5), 1994, pp. 160000098-160000098
Citation: Cs. Ryan et al., ACCOUNTING FOR CASE MANAGER EFFECTS IN THE EVALUATION OF MENTAL-HEALTH-SERVICES, Journal of consulting and clinical psychology, 62(5), 1994, pp. 965-974